[go: up one dir, main page]

NO20024046L - Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav - Google Patents

Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav Download PDF

Info

Publication number
NO20024046L
NO20024046L NO20024046A NO20024046A NO20024046L NO 20024046 L NO20024046 L NO 20024046L NO 20024046 A NO20024046 A NO 20024046A NO 20024046 A NO20024046 A NO 20024046A NO 20024046 L NO20024046 L NO 20024046L
Authority
NO
Norway
Prior art keywords
group
carbon atoms
atom
substituent
compound
Prior art date
Application number
NO20024046A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024046D0 (no
Inventor
Tatsuru Saito
Toshiaki Jouno
Yuichiro Tani
Toshifumi Akiba
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20024046D0 publication Critical patent/NO20024046D0/no
Publication of NO20024046L publication Critical patent/NO20024046L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20024046A 2000-02-25 2002-08-23 Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav NO20024046L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000054349 2000-02-25
JP2000117208 2000-04-13
PCT/JP2001/001370 WO2001062734A1 (en) 2000-02-25 2001-02-23 Process for producing quinolonecarboxylic acids and intermediates thereof

Publications (2)

Publication Number Publication Date
NO20024046D0 NO20024046D0 (no) 2002-08-23
NO20024046L true NO20024046L (no) 2002-10-24

Family

ID=26586419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024046A NO20024046L (no) 2000-02-25 2002-08-23 Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav

Country Status (10)

Country Link
EP (1) EP1258478A4 (ja)
KR (1) KR20020075447A (ja)
CN (1) CN1426399A (ja)
AU (1) AU2001234159A1 (ja)
CA (1) CA2400819A1 (ja)
HK (1) HK1048119A1 (ja)
IL (1) IL151451A0 (ja)
NO (1) NO20024046L (ja)
RU (1) RU2002122758A (ja)
WO (1) WO2001062734A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2299205C2 (ru) * 2000-02-09 2007-05-20 Дайити Фармасьютикал Ко., Лтд. Средство против кислотоустойчивых бактерий, содержащее пиридонкарбоновые кислоты в качестве активного компонента
EP1669354B1 (en) * 2003-09-29 2013-03-20 Daiichi Sankyo Company, Limited 8-cyanoquinolonecarboxylic acid derivative
CN1305849C (zh) * 2004-12-29 2007-03-21 江苏正大天晴药业股份有限公司 3-甲氨基哌啶及其盐的制备方法
CN101830815B (zh) * 2010-03-03 2014-01-29 伊泰(北京)合成技术有限公司 环状化合物及以其作为中间体制备氮杂螺环化合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
TW252107B (ja) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
DE4342186A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
WO1996022988A1 (en) * 1995-01-24 1996-08-01 Hokuriku Seiyaku Co., Ltd. Quinolinecarboxylic acid derivatives
KR19990071558A (ko) * 1995-11-22 1999-09-27 스즈키 다다시 치환된 아미노시클로알킬피롤리딘 유도체
JP4148550B2 (ja) * 1997-11-26 2008-09-10 イハラケミカル工業株式会社 5−アミノ−1−シクロプロピル−4−オキソキノリン−3−カルボン酸誘導体とその製造方法
JP2000247970A (ja) * 1999-02-26 2000-09-12 Hokuriku Seiyaku Co Ltd 5−アミノ−8−メチル−7−ピロリジニルキノリン−3−カルボン酸誘導体の製造法及びその製造中間体
JP2000319261A (ja) * 1999-05-13 2000-11-21 Dai Ichi Seiyaku Co Ltd キノロンカルボン酸類の製造方法

Also Published As

Publication number Publication date
EP1258478A1 (en) 2002-11-20
CA2400819A1 (en) 2001-08-30
RU2002122758A (ru) 2004-01-10
NO20024046D0 (no) 2002-08-23
KR20020075447A (ko) 2002-10-04
CN1426399A (zh) 2003-06-25
HK1048119A1 (en) 2003-03-21
IL151451A0 (en) 2003-04-10
WO2001062734A1 (en) 2001-08-30
AU2001234159A1 (en) 2001-09-03
EP1258478A4 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
CA2645191C (en) Process for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof
EP3137449A1 (en) Process for the preparation of substituted cycloserines
US6184388B1 (en) Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
CA2238765A1 (en) Substituted aminocycloalkylpyrrolidine derivatives
US6391889B2 (en) Cis-substituted aminocyclopropane derivatives
US6825353B2 (en) Process for producing quinolonecarboxylic acids and intermediates thereof
US8378119B2 (en) Method for producing asymmetric tetrasubstituted carbon atom-containing compound
NO20024046L (no) Fremgangsmåte for fremstilling av kinolonkarboksylsyrer og mellomprodukter derav
JP2000319261A (ja) キノロンカルボン酸類の製造方法
CN100422170C (zh) 喹诺酮羧酸衍生物的制备方法
CN101652357B (zh) 喹诺酮羧酸衍生物的制备方法
JPWO2001062734A1 (ja) キノロンカルボン酸類の製造方法およびその中間体
US7842818B2 (en) Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
AU2011260964A1 (en) Process for preparation of 3-substituted-4-fluoropyrrolidine derivatives
Grošelj et al. Synthesis of Novel (S)-N-Boc-3-Pyrazolylalanine-Derived α-Amino Acids
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
EP1634879A1 (en) Method of selectively introducing amino substituent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application